Skip to main navigation Skip to search Skip to main content

The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys

  • on behalf of the WHO World Mental Health Survey Collaborators
  • Institute for Development Research Advocacy and Applied Care (IDRAAC)
  • Harvard Medical School
  • Wroclaw Medical University
  • UC Davis Eye Center
  • Al-Qadisiyah University
  • University of São Paulo
  • Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz
  • IRCCS Istituto Centro San Giovanni di Dio-Fatebenefratelli
  • National School of Public Health
  • University College Hospital Ibadan
  • Universitat de Barcelona
  • Shenzhen Institute of Mental Health
  • Shenzhen Kangning Hospital
  • University of Balamand
  • St George Hospital University Medical Center
  • Chinese University of Hong Kong
  • Instituto Salud Carlos III
  • University of Ulster
  • University of Michigan, Ann Arbor
  • National Institute of Health
  • Universidad Peruana Cayetano Heredia
  • El Bosque University
  • Trimbos Institute, Netherlands Institute of Mental Health and Addiction
  • CES University
  • NOVA Medical School - Faculdade de Ciências Médicas, Universidade Nova de Lisboa

Research output: Contribution to journalArticlepeer-review

687 Scopus citations

Abstract

We previously reported on the cross-national epidemiology of ADHD from the first 10 countries in the WHO World Mental Health (WMH) Surveys. The current report expands those previous findings to the 20 nationally or regionally representative WMH surveys that have now collected data on adult ADHD. The Composite International Diagnostic Interview (CIDI) was administered to 26,744 respondents in these surveys in high-, upper-middle-, and low-/lower-middle-income countries (68.5% mean response rate). Current DSM-IV/CIDI adult ADHD prevalence averaged 2.8% across surveys and was higher in high (3.6%)- and upper-middle (3.0%)- than low-/lower-middle (1.4%)-income countries. Conditional prevalence of current ADHD averaged 57.0% among childhood cases and 41.1% among childhood subthreshold cases. Adult ADHD was significantly related to being male, previously married, and low education. Adult ADHD was highly comorbid with DSM-IV/CIDI anxiety, mood, behavior, and substance disorders and significantly associated with role impairments (days out of role, impaired cognition, and social interactions) when controlling for comorbidities. Treatment seeking was low in all countries and targeted largely to comorbid conditions rather than to ADHD. These results show that adult ADHD is prevalent, seriously impairing, and highly comorbid but vastly under-recognized and undertreated across countries and cultures.

Original languageEnglish
Pages (from-to)47-65
Number of pages19
JournalADHD Attention Deficit and Hyperactivity Disorders
Volume9
Issue number1
DOIs
StatePublished - 1 Mar 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • ADHD
  • Attention-deficit/hyperactivity disorder
  • Comorbidity
  • Disability epidemiology
  • Impairment
  • Prevalence
  • Treatment

Fingerprint

Dive into the research topics of 'The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys'. Together they form a unique fingerprint.

Cite this